OGT Launches New Website Providing Authoritative Resource Aiding Molecular Medicine and Research
Oxford, UK, Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has launched its brand new website. The new content-rich site provides authoritative insight into the latest developments, tools and issues in genomics research. Intuitive navigation makes it easy for users to find relevant resources matching their requirements, including insightful whitepapers and application notes, discussion topics via the new forum section, as well as detailed information on OGT’s products and services.
The new site utilises a totally new webpage design that maximises usability. Particular emphasis has been given to encouraging customer interaction and feedback though the use of discussion boards, opinion polls, social media sharing and the facility to post comments on all articles and news items. All content is connected and indexed ensuring that users always find what they are looking for, while suggesting relevant additional pages to aid user discovery. The unique navigation structure allows users to rapidly select the most relevant research area for their needs from clinical genetics, genomic services and diagnostic biomarkers.
About Oxford Gene Technology
Founded by Professor Ed Southern, Oxford Gene Technology (OGT) provides innovative clinical genetics and diagnostic solutions to advance molecular medicine. www.ogt.co.uk.
Clinical & Genomic Solutions: OGT’s Genefficiency™ is a unique combination of world-leading platforms, people, processing power and performance synchronised to deliver rapid, high-quality genomic data to customers worldwide. OGT’s CytoSure™ cytogenetics array, labelling and interpretation software products and services provide a complete solution for the detection of chromosomal abnormalities. Together, Genefficiency and CytoSure offer a unique, standardised and integrated solution for cytogenetics research.
Biomarker Discovery: OGT delivers tailored biomarker discovery solutions that optimise drug and diagnostic development programmes. With expertise in genomic and proteomic diagnostic biomarkers, OGT provides highly specific customised biomarker panels for cancer and other diseases, both for direct sale and also for collaboration with partner companies.

